A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins.
Fibriansah, G., Tan, J.L., Smith, S.A., de Alwis, R., Ng, T.S., Kostyuchenko, V.A., Jadi, R.S., Kukkaro, P., de Silva, A.M., Crowe, J.E., Lok, S.M.(2015) Nat Commun 6: 6341-6341
- PubMed: 25698059 
- DOI: 10.1038/ncomms7341
- Primary Citation of Related Structures:  
3J6S, 3J6T, 3J6U - PubMed Abstract: 
Dengue virus (DENV) infects ~400 million people annually. There is no licensed vaccine or therapeutic drug. Only a small fraction of the total DENV-specific antibodies in a naturally occurring dengue infection consists of highly neutralizing antibodies. Here we show that the DENV-specific human monoclonal antibody 5J7 is exceptionally potent, neutralizing 50% of virus at nanogram-range antibody concentration ...